New blood test thresholds could sharpen diagnosis of hidden high blood pressure cause
NCT ID NCT05640128
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 105 people to find the best blood test values for diagnosing primary hyperaldosteronism, a condition where the adrenal glands make too much aldosterone hormone, causing high blood pressure. Researchers measured aldosterone and renin levels using advanced lab methods in healthy volunteers, people with essential hypertension, and those with primary hyperaldosteronism. The goal was to set clearer cutoff numbers for screening and confirming the condition, which could help doctors identify and treat it more accurately.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to more accurate and earlier diagnosis of primary hyperaldosteronism, helping doctors choose the right treatment for high blood pressure.
What could go wrong
This is a small, completed study focused on setting reference ranges, not testing a treatment. The results may not apply to all patient groups or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAEN University Hospital
Caen, France